Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decision analysis in the formulary process

J M Kessler1

  • 1School of Pharmacy, University of North Carolina, Durham, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|December 16, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Lipid-lowering drugs, cost-effectiveness data, and the formulary system: a health systems perspective.

American heart journal·1999
Same author

Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996
Same author

Drug allergies, adverse drug reactions, and the patient record.

American journal of hospital pharmacy·1993
Same author

Use of antimicrobial drugs in adults before and after removal of a restriction policy.

American journal of hospital pharmacy·1991
Same author

Erythromycin-carbamazepine interaction.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1985
Same author

Disopyramide and phenytoin interaction.

Clinical pharmacy·1982
Same journal

Iodixanol-induced acute generalized exanthematous pustulosis: Cross-reactivity to other iodinated contrast media.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Sonrotoclax.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Bulevirtide Acetate-gmod.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Addressing feedback overload in pharmacy residents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Development of a psychiatric pharmacy internship program at a children's hospital.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Integration of smart infusion pumps with electronic medical records improves safety and staff productivity at a large academic healthcare system.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
See all related articles

Decision analysis aids formulary decisions by evaluating total treatment costs beyond acquisition expenses. This method uses probabilities and costs for treatments and outcomes, proving valuable for complex healthcare choices.

Area of Science:

  • Health Economics
  • Decision Science
  • Pharmacoeconomics

Background:

  • Formulary decisions traditionally focus on acquisition costs.
  • Complex treatment pathways necessitate a broader cost-benefit analysis.

Purpose of the Study:

  • To discuss the application of decision analysis in healthcare formulary decision-making.
  • To highlight the benefits of decision analysis when non-acquisition costs are significant.

Main Methods:

  • Decision analysis involves assigning probabilities and costs to treatments and outcomes.
  • Data from clinical trials or expert panels are used to estimate these values.
  • Models must be evaluated for robustness and adaptability to local clinical practice.

Main Results:

Related Experiment Videos

  • Decision analysis is most effective when comparing treatments with significant non-acquisition cost differences.
  • Models should incorporate all relevant interventions and clearly define financial perspectives.
  • Internal hospital data are crucial for developing accurate and applicable models.

Conclusions:

  • Decision analysis offers a structured approach to complex formulary decisions, moving beyond simple cost comparisons.
  • Challenges include data availability and standardization, but the technique is increasingly relevant for clinicians and policymakers.
  • Ongoing monitoring and adjustments are essential for effective resource allocation post-implementation.